A pharma CEO says a new depression drug could have lasting effects after one short course, like antibiotics — here’s what experts think
Investors’ excitement about a promising new drug for depression reached a fever pitch last week when the CEO of the company behind it likened the drug to an antibiotic. This drug hasRead More…